Sales & Marketing News | pharmaphorum

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

News

Novartis weathers Entresto slump with return to growth

Novartis saw sales grow 3% in the second quarter, returning to growth after a 1% fall in the first quarter caused by generic competition to Entresto.

News

Samsung Biologics agrees $1.81bn takeover of PolyPeptide

Samsung Biologics has agreed to buy PolyPeptide, a Swiss CDMO, in what is thought to be South Korea's largest biopharma acquisition to date.

News

MSD gets first FDA okay for oral PCSK9 cholesterol drug

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.

News

Novo's Wegovy pill cleared for weight loss in EU

The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.

Trump sets course for 100%, then 200%, tariffs on generics

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Novartis weathers Entresto slump with return to growth

Samsung Biologics agrees $1.81bn takeover of PolyPeptide

MSD gets first FDA okay for oral PCSK9 cholesterol drug

Novo's Wegovy pill cleared for weight loss in EU

ESMO26: Lily's sofe-m ADC stakes a claim in ovarian cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks